MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy
Human malignant melanoma shows a high rate of mortality after metastasization, and its incidence is continuously rising worldwide. Several studies have suggested that MCAM/MUC18/CD146 plays an important role in the progression of this malignant disease. MCAM/MUC18/CD146 is a typical single-spanning...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a30d42c08c843d5a4a9c43fc41a85f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7a30d42c08c843d5a4a9c43fc41a85f4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7a30d42c08c843d5a4a9c43fc41a85f42021-11-25T17:56:28ZMCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy10.3390/ijms2222124161422-00671661-6596https://doaj.org/article/7a30d42c08c843d5a4a9c43fc41a85f42021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12416https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Human malignant melanoma shows a high rate of mortality after metastasization, and its incidence is continuously rising worldwide. Several studies have suggested that MCAM/MUC18/CD146 plays an important role in the progression of this malignant disease. MCAM/MUC18/CD146 is a typical single-spanning transmembrane glycoprotein, existing as two membrane isoforms, long and short, and an additional soluble form, sCD146. We previously documented that molecular MCAM/MUC18/CD146 expression is strongly associated with disease progression. Recently, we showed that MCAM/MUC18/CD146 and ABCB5 can serve as melanoma-specific-targets in the selection of highly primitive circulating melanoma cells, and constitute putative proteins associated with disease spreading progression. Here, we analyzed CD146 molecular expression at onset or at disease recurrence in an enlarged melanoma case series. For some patients, we also performed the time courses of molecular monitoring. Moreover, we explored the role of soluble CD146 in different cohorts of melanoma patients at onset or disease progression, rather than in clinical remission, undergoing immune therapy or free from any clinical treatment. We showed that MCAM/MUC18/CD146 can be considered as: (1) a membrane antigen suitable for identification and enrichment in melanoma liquid biopsy; (2) a highly effective molecular “warning” marker for minimal residual disease monitoring; and (3) a soluble protein index of inflammation and putative response to therapeutic treatments.Maria Cristina RapanottiElisa CuginiMarzia NuccetelliAlessandro TerrinoniCosimo Di RaimondoPaolo LombardoGaetana CostanzaTerenzio CosioPiero RossiAugusto OrlandiElena CampioneSergio BernardiniMarcel Blot-ChabaudLuca BianchiMDPI AGarticleMCAM/MUC18/CD146soluble CD146liquid biopsycirculating melanoma cells (CMCs)gene-expression panelBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12416, p 12416 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
MCAM/MUC18/CD146 soluble CD146 liquid biopsy circulating melanoma cells (CMCs) gene-expression panel Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
MCAM/MUC18/CD146 soluble CD146 liquid biopsy circulating melanoma cells (CMCs) gene-expression panel Biology (General) QH301-705.5 Chemistry QD1-999 Maria Cristina Rapanotti Elisa Cugini Marzia Nuccetelli Alessandro Terrinoni Cosimo Di Raimondo Paolo Lombardo Gaetana Costanza Terenzio Cosio Piero Rossi Augusto Orlandi Elena Campione Sergio Bernardini Marcel Blot-Chabaud Luca Bianchi MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy |
description |
Human malignant melanoma shows a high rate of mortality after metastasization, and its incidence is continuously rising worldwide. Several studies have suggested that MCAM/MUC18/CD146 plays an important role in the progression of this malignant disease. MCAM/MUC18/CD146 is a typical single-spanning transmembrane glycoprotein, existing as two membrane isoforms, long and short, and an additional soluble form, sCD146. We previously documented that molecular MCAM/MUC18/CD146 expression is strongly associated with disease progression. Recently, we showed that MCAM/MUC18/CD146 and ABCB5 can serve as melanoma-specific-targets in the selection of highly primitive circulating melanoma cells, and constitute putative proteins associated with disease spreading progression. Here, we analyzed CD146 molecular expression at onset or at disease recurrence in an enlarged melanoma case series. For some patients, we also performed the time courses of molecular monitoring. Moreover, we explored the role of soluble CD146 in different cohorts of melanoma patients at onset or disease progression, rather than in clinical remission, undergoing immune therapy or free from any clinical treatment. We showed that MCAM/MUC18/CD146 can be considered as: (1) a membrane antigen suitable for identification and enrichment in melanoma liquid biopsy; (2) a highly effective molecular “warning” marker for minimal residual disease monitoring; and (3) a soluble protein index of inflammation and putative response to therapeutic treatments. |
format |
article |
author |
Maria Cristina Rapanotti Elisa Cugini Marzia Nuccetelli Alessandro Terrinoni Cosimo Di Raimondo Paolo Lombardo Gaetana Costanza Terenzio Cosio Piero Rossi Augusto Orlandi Elena Campione Sergio Bernardini Marcel Blot-Chabaud Luca Bianchi |
author_facet |
Maria Cristina Rapanotti Elisa Cugini Marzia Nuccetelli Alessandro Terrinoni Cosimo Di Raimondo Paolo Lombardo Gaetana Costanza Terenzio Cosio Piero Rossi Augusto Orlandi Elena Campione Sergio Bernardini Marcel Blot-Chabaud Luca Bianchi |
author_sort |
Maria Cristina Rapanotti |
title |
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy |
title_short |
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy |
title_full |
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy |
title_fullStr |
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy |
title_full_unstemmed |
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy |
title_sort |
mcam/muc18/cd146 as a multifaceted warning marker of melanoma progression in liquid biopsy |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/7a30d42c08c843d5a4a9c43fc41a85f4 |
work_keys_str_mv |
AT mariacristinarapanotti mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT elisacugini mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT marzianuccetelli mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT alessandroterrinoni mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT cosimodiraimondo mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT paololombardo mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT gaetanacostanza mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT terenziocosio mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT pierorossi mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT augustoorlandi mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT elenacampione mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT sergiobernardini mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT marcelblotchabaud mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy AT lucabianchi mcammuc18cd146asamultifacetedwarningmarkerofmelanomaprogressioninliquidbiopsy |
_version_ |
1718411811366109184 |